Literature DB >> 12780747

Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men.

Michael J Diver1, Komal E Imtiaz, Aftab M Ahmad, Jiten P Vora, William D Fraser.   

Abstract

BACKGROUND: Conflicting views are reported on the association between advancing age and gradually diminishing concentrations of serum total testosterone in men. The putative loss of diurnal rhythm in serum total testosterone in older men is reported to be in part due to low concentrations in the morning when compared to concentrations found in young men. We have measured total, free and bioavailable testosterone along with SHBG in samples taken every 30 min throughout a 24-h period in 10 young and eight middle-aged men.
RESULTS: Both young and middle-aged men displayed a significant diurnal rhythm in all variables, with a minimum fall of 43% in total testosterone from peak to nadir in all subjects. Subjecting the data to a time series analysis by least squares estimation revealed no significant difference in mesor (P = 0.306), amplitude (P = 0.061) or acrophase (P = 0.972) for total testosterone between the two groups. Comparing bioavailable testosterone in the two groups revealed no significant difference in mesor (P = 0.175) or acrophase (P = 0.978) but a significant difference (P = 0.031) in amplitude. Both groups display a significant circadian rhythm (middle-aged group P < 0.001; young group P = 0.014). Free testosterone revealed a highly significant rhythm in both the young group (P < 0.001) and the middle-aged group (P = 0.002), with no significant difference between the groups in mesor (P = 0.094) or acrophase (P = 0.698). Although analysis of the SHBG data revealed a significant rhythm in the young group (P = 0.003) and the older group (P < 0.001), the acrophase occurred in the mid afternoon in both groups (15.12 h in the young and 15.40 h in the middle-aged). The older men had a significantly greater amplitude (P = 0.044) but again no significant difference was seen in mesor (P = 0.083) or acrophase (P = 0.477) between the two groups. Acrophases for total, bioavailable and free testosterone occurred between 07.00 h and 07.30 h; for SHBG the acrophase occurred at 15.12 h in the young group and 15.40 h in the middle-aged group.
CONCLUSIONS: The study suggests that the diurnal rhythm in these indices of androgen status is maintained in fit, healthy men into the 7th decade of life.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12780747     DOI: 10.1046/j.1365-2265.2003.01772.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  61 in total

Review 1.  [Testosterone deficiency and the problem of normal values].

Authors:  H M Behre
Journal:  Urologe A       Date:  2004-09       Impact factor: 0.639

2.  An improved micro-method for the measurement of steroid profiles by APPI-LC-MS/MS and its use in assessing diurnal effects on steroid concentrations and optimizing the diagnosis and treatment of adrenal insufficiency and CAH.

Authors:  Brian R Stolze; Verena Gounden; Jianghong Gu; Elizabeth A Elliott; Likhona S Masika; Brent S Abel; Deborah P Merke; Monica C Skarulis; Steven J Soldin
Journal:  J Steroid Biochem Mol Biol       Date:  2015-12-22       Impact factor: 4.292

3.  Extinction of conditioned fear is better learned and recalled in the morning than in the evening.

Authors:  Edward F Pace-Schott; Rebecca M C Spencer; Shilpa Vijayakumar; Nafis A K Ahmed; Patrick W Verga; Scott P Orr; Roger K Pitman; Mohammed R Milad
Journal:  J Psychiatr Res       Date:  2013-08-28       Impact factor: 4.791

4.  Andropause: need for concrete guidelines until more evidence becomes available.

Authors:  S Basaria
Journal:  J Endocrinol Invest       Date:  2005 Jul-Aug       Impact factor: 4.256

Review 5.  A Clinical Perspective of Sleep and Andrological Health: Assessment, Treatment Considerations, and Future Research.

Authors:  Peter Y Liu
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

Review 6.  WOMEN IN CANCER THEMATIC REVIEW: Circadian rhythmicity and the influence of 'clock' genes on prostate cancer.

Authors:  Zsofia Kiss; Paramita M Ghosh
Journal:  Endocr Relat Cancer       Date:  2016-09-22       Impact factor: 5.678

7.  The natural history of symptomatic androgen deficiency in men: onset, progression, and spontaneous remission.

Authors:  Thomas G Travison; Rebecca Shackelton; Andre B Araujo; Susan A Hall; Rachel E Williams; Richard V Clark; Amy B O'Donnell; John B McKinlay
Journal:  J Am Geriatr Soc       Date:  2008-05       Impact factor: 5.562

Review 8.  Testosterone replacement therapy and prostate cancer: a word of caution.

Authors:  Timothy C Brand; Edith Canby-Hagino; Ian M Thompson
Journal:  Curr Urol Rep       Date:  2007-05       Impact factor: 3.092

9.  The benefits and risks of testosterone replacement therapy: a review.

Authors:  Nazem Bassil; Saad Alkaade; John E Morley
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423

10.  Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations.

Authors:  C Wang; E Nieschlag; R Swerdloff; H M Behre; W J Hellstrom; L J Gooren; J M Kaufman; J-J Legros; B Lunenfeld; A Morales; J E Morley; C Schulman; I M Thompson; W Weidner; F C W Wu
Journal:  Eur J Endocrinol       Date:  2008-11       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.